# Subquery 2 — Silhouette Score Thresholds in Clinical Clustering

- **Date:** 2026-04-04
- **Provider:** Perplexity
- **Query:** `acceptable silhouette score threshold medical clinical clustering healthcare machine learning what is considered good`

## Short answer

There is **no universal medical-only cutoff** for silhouette score quality. In clinical clustering papers, silhouette is typically treated as a **heuristic internal-validity metric**, then weighed alongside stability, external validation, and clinical interpretability.

Practical rule-of-thumb ranges commonly used:

- **< 0.20** → poor / very weak separation
- **0.20–0.40** → weak to modest structure
- **0.40–0.60** → moderate / good structure
- **> 0.60** → strong structure

## Is **0.18** reasonable for healthcare data?

**Yes, potentially reasonable (but weak)** in real-world clinical datasets—especially EHR phenotyping/subtyping—when authors can show:

1. **Cluster stability** across resampling/folds or independent cohorts.
2. **Clinical usefulness** (distinct outcomes, risk trajectories, treatment-response patterns, or phenotype meaning).
3. **Transparent reporting** that acknowledges weak geometric separation.
4. **Multi-metric validation** (not silhouette alone; e.g., CH/DB/BIC/elbow + external/clinical validation).

So, **0.18 is usually not “good” separation**, but it can still be **publishable and defensible** in messy, heterogeneous healthcare data if downstream clinical signal is credible.

## What papers say about low scores in real-world clinical datasets

Across healthcare clustering literature (as summarized in the Perplexity result), low-to-modest silhouette scores are often linked to:

- **Biological heterogeneity** and overlapping disease phenotypes.
- **EHR noise/sparsity** (coding variability, missingness, mixed variable types).
- **Longitudinal irregularity** (uneven visit spacing, variable trajectory lengths).
- **High-dimensional representations** where clear geometric separation is difficult.

In these contexts, papers often prioritize **clinical face validity and reproducibility** over high silhouette values.

## Source set surfaced by Perplexity

Primary links shown in the answer’s source panel:

- https://pmc.ncbi.nlm.nih.gov/articles/PMC11807335/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC8234541/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC9035269/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC11868038/
- https://aging.jmir.org/2025/1/e65178/
- https://www.frontiersin.org/journals/digital-health/articles/10.3389/fdgth.2023.1142822/full
- https://www.nature.com/articles/s41598-024-78794-5
- https://www.sciencedirect.com/science/article/pii/S0165178123002159
- https://www.sciencedirect.com/science/article/pii/S0933365724001477
- https://www.sciencedirect.com/science/article/pii/S2352914824001291

Also surfaced (lower-tier / conference or non-indexed in many cases):

- https://aircconline.com/ijcsit/V10N2/10218ijcsit03.pdf
- https://zenodo.org/records/1248795
- https://conference.ioe.edu.np/publications/ioegc12/IOEGC-12-206-12302.pdf
- https://biomedpharmajournal.org/vol18no3/clustering-medical-conditions-in-patient-records-using-unsupervised-learning-techniques-a-comparative-study/
- https://jurnal.fikom.umi.ac.id/index.php/ILKOM/article/download/2325/pdf

## Interpretation for this project

For thesis/defense language: describe **0.18 as weak internal separation**, then justify acceptability via **clinical relevance + robustness checks** rather than claiming strong cluster compactness.
